Evaluating the Pharmacokinetics and Safety of Miricorilant | MicrobiomeTrials← Back to trialsNCT07553663
Evaluating the Pharmacokinetics and Safety of Miricorilant
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2026-04-30Est. Completion: 2026-09-22
Enrollment target: 14 participants Locations- Site# 433, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Obesity
Background:
Obesity affects 1 in 5 children in the United States. Childhood obesity often persists into adolescence and…
Research Triangle Park, United StatesEst. completion Dec 23, 2036
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease calle…
Tucson, United StatesEst. completion Jan 29, 2029
Recruiting
Overweight and/or ObesityMetabolic SyndromeNonalcoholic Fatty Liver Disease
This randomized, sham-controlled trial evaluates the efficacy and safety of ERCG plus optimized lifestyle intervention c…
Beijing, ChinaEst. completion Mar 30, 2027